Search

Your search keyword '"Danieli, E"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Danieli, E" Remove constraint Author: "Danieli, E"
228 results on '"Danieli, E"'

Search Results

3. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

4. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

5. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data

6. Variation in paediatric hospital antibiotic guidelines in Europe

8. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

11. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

12. Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)

13. Peripheral Oxidative Stress Markers Are Related To Vascular Risk Factors And Subcortical Small Vessel Disease

15. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

16. Corrigendum to 'Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV' [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)

17. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

18. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

20. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

21. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

22. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data

23. Variation in paediatric hospital antibiotic guidelines in Europe

24. Changes of lipid profile after switching to E/C/F/TAF: data from the Italian Compassionate Use Program

25. Compassionate use of tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: an Italian experience

26. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

27. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data

28. Variation in paediatric hospital antibiotic guidelines in Europe

29. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life

30. Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort

31. Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe

33. Biphasic Kinetics of HCV-RNA Decay is Accompanied by an even Faster Aminotransferases Normalization in All-Daa Treated Cirrhotic Patients: A Different Scenario from Interferon-Based Therapies

34. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide

35. Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study

46. Mediziner-Literaturrätsel

47. Mediziner-Literaturrätsel

48. FRI-196 - Biphasic Kinetics of HCV-RNA Decay is Accompanied by an even Faster Aminotransferases Normalization in All-Daa Treated Cirrhotic Patients: A Different Scenario from Interferon-Based Therapies

50. Impact of in utero environment on the offspring of lupus patients

Catalog

Books, media, physical & digital resources